Search Results - "Mestier, Louis"

Refine Results
  1. 1

    European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours by Kos‐Kudła, Beata, Castaño, Justo P., Denecke, Timm, Grande, Enrique, Kjaer, Andreas, Koumarianou, Anna, Mestier, Louis, Partelli, Stefano, Perren, Aurel, Stättner, Stefan, Valle, Juan W., Fazio, Nicola

    Published in Journal of neuroendocrinology (01-12-2023)
    “…This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary…”
    Get full text
    Journal Article
  2. 2

    Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor by de Mestier, Louis, Walter, Thomas, Evrard, Camille, de Boissieu, Paul, Hentic, Olivia, Cros, Jérôme, Tougeron, David, Lombard-Bohas, Catherine, Rebours, Vinciane, Hammel, Pascal, Ruszniewski, Philippe

    Published in Neuroendocrinology (01-01-2020)
    “…The combination of capecitabine (CAP) with temozolomide (TEM) chemotherapy in advanced pancreatic neuroendocrine tumors (PanNET) relies on limited evidence. We…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies by Turpin, Anthony, Neuzillet, Cindy, Colle, Elise, Dusetti, Nelson, Nicolle, Rémy, Cros, Jérôme, de Mestier, Louis, Bachet, Jean-Baptiste, Hammel, Pascal

    “…Mortality from pancreatic ductal adenocarcinoma (PDAC) is increasing worldwide and effective new treatments are urgently needed. The current treatment of…”
    Get full text
    Book Review Journal Article
  5. 5
  6. 6
  7. 7

    FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors by Lacombe, Caroline, Perrier, Marine, Hentic, Olivia, Brixi, Hedia, De Rycke, Ophélie, Cros, Jérôme, Rebours, Vinciane, Cadiot, Guillaume, Ruszniewski, Philippe, Mestier, Louis

    Published in Journal of neuroendocrinology (01-01-2023)
    “…Neuroendocrine tumors (NETs) are highly vascularized neoplasms. While FOLFOX chemotherapy has shown efficacy in patients with advanced NETs, its combination…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Are recist criteria adequate in assessing the response to therapy in metastatic NEN? by Vullierme, Marie-Pierre, Ruszniewski, Philippe, de Mestier, Louis

    Published in Reviews in endocrine & metabolic disorders (01-09-2021)
    “…Response to therapy criteria, known as RECIST (Response Evaluation Criteria in Solid Tumours), are widely used to evaluate neuroendocrine tumours (NET)…”
    Get full text
    Journal Article
  10. 10

    Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components by Zhao, Shulin, Nicolle, Rémy, Augustin, Jérémy, Svrcek, Magali, de Mestier, Louis, Le Corre, Delphine, Pietrasz, Daniel, Caliez, Olivier, Cros, Jérôme, Laurent-Puig, Pierre, Bachet, Jean-Baptiste

    Published in Clinical cancer research (01-12-2021)
    “…Our team previously defined six quantitative transcriptomic components, and a classification in five subtypes by association of these components. In this…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Absorbable Polyglactin vs. Non-Cross-linked Porcine Biological Mesh for the Surgical Treatment of Infected Incisional Hernia by Renard, Yohann, de Mestier, Louis, Henriques, Julie, de Boissieu, Paul, de Mestier, Philippe, Fingerhut, Abe, Palot, Jean-Pierre, Kianmanesh, Reza

    Published in Journal of gastrointestinal surgery (01-02-2020)
    “…Background The use of absorbable meshes during contaminated or infected incisional hernia (IH) repair is associated with high morbidity and recurrence rates…”
    Get full text
    Journal Article
  14. 14

    Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms by Gay-Chevallier, Servane, de Mestier, Louis, Perinel, Julie, Forestier, Julien, Hervieu, Valérie, Ruszniewski, Philippe, Millot, Ingrid, Valette, Pierre-Jean, Pioche, Mathieu, Lombard-Bohas, Catherine, Subtil, Fabien, Adham, Mustapha, Walter, Thomas

    Published in Neuroendocrinology (01-07-2021)
    “…The characteristics, prognostic factors, and management of duodenal neuroendocrine neoplasms (dNEN) are ill-defined, given their rarity. Whether nonsurgical…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Unraveling Pancreatic Segmentation by Renard, Yohann, de Mestier, Louis, Perez, Manuela, Avisse, Claude, Lévy, Philippe, Kianmanesh, Reza

    Published in World journal of surgery (01-04-2018)
    “…Background Limited pancreatic resections are increasingly performed, but the rate of postoperative fistula is higher than after classical resections…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Carcinoid heart disease in patients with midgut neuroendocrine tumours by Delhomme, Clémence, Walter, Thomas, Arangalage, Dimitri, Suc, Gaspard, Hentic, Olivia, Cachier, Agnès, Alkhoder, Soleiman, François, Laurent, Lombard‐Bohas, Catherine, Iung, Bernard, Ruszniewski, Philippe, Mestier, Louis

    Published in Journal of neuroendocrinology (01-04-2023)
    “…Carcinoid heart disease (CHD) is the main complication of carcinoid syndrome (CS) associated with metastatic small intestine neuroendocrine tumours (NETs). The…”
    Get full text
    Journal Article
  20. 20

    Prognostic impact of bone metastases detected by 18F-DOPA PET in patients with metastatic midgut neuroendocrine tumors by Deleval, Nicolas, Pesque, Louise, Dieudonné, Arnaud, Viry, Flore, Hentic, Olivia, Lebtahi, Rachida, Ruszniewski, Philippe, de Mestier, Louis

    Published in European radiology (01-06-2021)
    “…Objectives Bone metastases (BM) may influence negatively the prognosis of midgut neuroendocrine tumors (NET). The diagnostic sensitivity of 18 F-DOPA PET for…”
    Get full text
    Journal Article